Search research articles
Contact Us
Filters
Showing results (681-690 of 717) with videos related to
Page
of 72
Sort By:
Journal of the National Cancer Institute
|
September 21, 2006
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk
Timothy R Rebbeck, Andrea B Troxel, Yiting Wang, et al.
JCI Insight
|
November 3, 2020
Stem cell and niche regulation in human short bowel syndrome
Vered A Gazit, Elzbieta A Swietlicki, Miranda U Liang, et al.
Gynecologic Oncology
|
March 19, 2018
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study
Ramez N Eskander, James Kauderer, Krishnansu S Tewari, et al.
The Journal of Nutrition
|
September 24, 2010
Deletion of Tis7 protects mice from high-fat diet-induced weight gain and blunts the intestinal adaptive response postresection
Cong Yu, Shujun Jiang, Jianyun Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2006
A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis
Stephen M Hahn, Douglas L Fraker, Rosemarie Mick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study
Robert A Burger, Mark F Brady, Michael A Bookman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients
Katia Schlienger, Christina S Chu, Edward Y Woo, et al.
The Journal of Clinical Investigation
|
January 14, 2021
Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer
Valerie Blanc, Jesse D Riordan, Saeed Soleymanjahi, et al.
The Journal of Clinical Investigation
|
June 2, 2025
Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer
Valerie Blanc, Jesse D Riordan, Saeed Soleymanjahi, et al.
Oncogene
|
December 20, 2011
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression
F Pareja, D A Ferraro, C Rubin, et al.
Page
of 72
Search research articles
Search
Showing results (681-690 of 717) with videos related to
Sort By:
Page
of 72
Journal of the National Cancer Institute
|
September 21, 2006
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk
Timothy R Rebbeck, Andrea B Troxel, Yiting Wang, et al.
JCI Insight
|
November 3, 2020
Stem cell and niche regulation in human short bowel syndrome
Vered A Gazit, Elzbieta A Swietlicki, Miranda U Liang, et al.
Gynecologic Oncology
|
March 19, 2018
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study
Ramez N Eskander, James Kauderer, Krishnansu S Tewari, et al.
The Journal of Nutrition
|
September 24, 2010
Deletion of Tis7 protects mice from high-fat diet-induced weight gain and blunts the intestinal adaptive response postresection
Cong Yu, Shujun Jiang, Jianyun Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2006
A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis
Stephen M Hahn, Douglas L Fraker, Rosemarie Mick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study
Robert A Burger, Mark F Brady, Michael A Bookman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients
Katia Schlienger, Christina S Chu, Edward Y Woo, et al.
The Journal of Clinical Investigation
|
January 14, 2021
Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer
Valerie Blanc, Jesse D Riordan, Saeed Soleymanjahi, et al.
The Journal of Clinical Investigation
|
June 2, 2025
Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer
Valerie Blanc, Jesse D Riordan, Saeed Soleymanjahi, et al.
Oncogene
|
December 20, 2011
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression
F Pareja, D A Ferraro, C Rubin, et al.
Page
of 72